Proactive Intervention: Strategies for Slowing Type 1 Diabetes Progression : Episode 5

Antibody Screening Tests for T1D

December 10, 2024

By Javier Morales, MD, FACP, FACE
Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCES

Opinion

Video

Panelists discuss how antibody screening tests for type 1 diabetes (T1D), including tests for insulin autoantibodies (IAA), glutamic acid decarboxylase (GAD) antibodies, and other markers can help identify individuals at risk for developing the disease before clinical symptoms appear, enabling earlier monitoring and potential intervention.

EP: 1.Assessing the Burden of T1D

EP: 2.Guidelines on Screening for T1D

EP: 3.Examining the Stages of T1D Progression

EP: 4.Consequences of Delaying Intervention in Stage 2 T1D

Now Viewing

EP: 5.Antibody Screening Tests for T1D

EP: 6.Who Should We Screen for T1D?

EP: 7.Facilities for Teplizumab Infusion

EP: 8.Teplizumab for Delaying Onset and Progression of T1D

EP: 9.Key Insights and Final Thoughts on Screening and Management of T1D

Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.

Subscribe Now!